Merck (MRK) Asset Utilization Ratio (2009 - 2026)
Merck (MRK) posted quarterly Asset Utilization Ratio of 0.5 for Q1 2026, down 10.02% year-over-year from 0.55 in Q1 2025, and up 1.49% quarter-over-quarter from 0.49 in Q4 2025.
Merck (MRK) Asset Utilization Ratio (2009 - 2026) Analysis & Trends
Merck (MRK) has reported Asset Utilization Ratio for 18 consecutive years, with 0.5 the latest figure, recorded in Q1 2026.
- In Q1 2026, Asset Utilization Ratio fell 10.02% year-over-year to 0.5; the TTM figure through Mar 2026 stood at 0.5 (down 10.02% YoY), while the FY2025 annual figure was 0.51, down 10.73% from the prior year.
- Asset Utilization Ratio grew to 0.5 in Q1 2026 per MRK's latest filing, from 0.49 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 0.58 in Q1 2024 and bottomed at 0.49 in Q4 2025.
- Historically, Asset Utilization Ratio has averaged 0.54 across 5 years, with a median of 0.55 in 2022.
- Annual changes were most pronounced in 2022 — Asset Utilization Ratio gained 12.12% — and 2025, when it declined 10.77%.
- Merck's Asset Utilization Ratio stood at 0.55 in 2022, then rose by 2.75% to 0.56 in 2023, then retreated by 2.92% to 0.55 in 2024, then slipped by 10.77% to 0.49 in 2025, then rose by 1.49% to 0.5 in 2026.
- Business Quant data shows MRK's Asset Utilization Ratio at 0.5 in Q1 2026, 0.49 in Q4 2025, and 0.52 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | 0.49 |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | 0.47 |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | 0.52 |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | 0.53 |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | 0.40 |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | 0.58 |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | 0.31 |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | 0.64 |
| 10 | Sanofi | 55.07 Bn | 47.69 Bn | 10.79 Bn | 0.36 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.52 |
| Mar 31, 2026 | 0.50 |
| Dec 31, 2025 | 0.49 |
| Sep 30, 2025 | 0.52 |
| Jun 30, 2025 | 0.55 |
| Mar 31, 2025 | 0.55 |
| Dec 31, 2024 | 0.55 |
| Sep 30, 2024 | 0.55 |
| Jun 30, 2024 | 0.57 |
| Mar 31, 2024 | 0.58 |
| Dec 31, 2023 | 0.56 |
| Sep 30, 2023 | 0.56 |
| Jun 30, 2023 | 0.55 |
| Mar 31, 2023 | 0.53 |
| Dec 31, 2022 | 0.55 |
| Sep 30, 2022 | 0.55 |
| Jun 30, 2022 | 0.53 |
| Mar 31, 2022 | 0.51 |
| Dec 31, 2021 | 0.49 |
| Sep 30, 2021 | 0.50 |